No Data
No Data
GeoVax Labs to Initiate Phase 2 Clinical Study of Gedeptin
Express News | GeoVax Announces Major Gedeptin Milestone With Plans Of Phase 2 Trial
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $12
GeoVax Labs, Inc. Secures U.S. Patent Notice of Allowance for Tumor Immunotherapy Technology
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Express News | GeoVax Receives Notice of Allowance for Cancer Vaccine Patent
Unlock the Full List